ArticleJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG2026
Chemotherapy-induced alopecia: an exploratory questionnaire-based study from Israel comparing knowledge, attitudes, and management practices among dermatologists and oncologists.
Article in Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesChemotherapy-induced alopecia, encompassing both acute reversible alopecia and its persistent form, significantly impacts patients' quality of life but remains inadequately addressed. This study aimed to compare dermatologists' and oncologists' knowledge, attitudes, and practices regarding chemotherapy-induced alopecia, as well as their awareness of scalp cooling as a preventive intervention. PATIENTS AND
methodsA cross-sectional survey was conducted in Israel at nine tertiary medical centers using a structured questionnaire to assess knowledge, attitudes, and practices related to chemotherapy-induced alopecia, including separately analyzed persistent chemotherapy-induced alopecia and scalp cooling. Responses from dermatologists and oncologists were compared, and factors influencing knowledge scores were identified.
resultsBoth groups demonstrated limited knowledge. Oncologists scored higher on acute chemotherapy-induced alopecia (mean 3.88 vs. 2.74, p < 0.001), while dermatologists tended to score higher on persistent chemotherapy-induced alopecia (mean 7.85 vs. 6.92, p = 0.063). Male participants scored lower than female participants (p = 0.050). Oncologists were more familiar with scalp cooling, citing cost and logistical issues as significant barriers; dermatologists emphasized the need for proactive care and education.
conclusionsSignificant knowledge gaps and differing practices between dermatologists and oncologists underscore the importance of targeted educational initiatives and interdisciplinary collaboration to improve patient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.